Skip to main content
Clinical Trials/NL-OMON51200
NL-OMON51200
Not yet recruiting
Not Applicable

Quantitative mpMRI to predict metastatic potential of prostate cancer - QmpMRI

Radboud Universitair Medisch Centrum0 sites30 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
30
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Histologically proven primary cancer of the prostate, based on prostate
  • biopsy\-core analysis.
  • \- Patient is scheduled and fit for PSMA\-PET/CT
  • \- Age\*50 years. Ability to give voluntary written informed consent to
  • participate in this study.

Exclusion Criteria

  • \- Contraindication for MRI\-scanning, i.e. claustrophobia, intracranial metal
  • clips, metallic bodies in the eye, implanted electric and electronic devices
  • not eligible for MRI (pacemakers, insulin pumps, cochlear implants,
  • neurostimulators).
  • \- Prior prostate cancer treatment.
  • \- Prior pelvic surgery, associated with pelvic lymphadenopathy
  • \- Presence of any medical condition that in the opinion of the
  • investigator/treating physician will affect patients\* clinical status by
  • participating in this trial.
  • \- Inability to lie still for 45 minutes or comply with imaging.

Outcomes

Primary Outcomes

Not specified

Similar Trials